These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 3570048)

  • 1. Treatment of a syngeneic rat tumor with magnetically responsive albumin microspheres labeled with doxorubicin or protein A.
    Rettenmaier MA; Stratton JA; Berman ML; Senyei A; Widder K; White DB; DiSaia PJ
    Gynecol Oncol; 1987 May; 27(1):34-43. PubMed ID: 3570048
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tumor remission in Yoshida sarcoma-bearing rts by selective targeting of magnetic albumin microspheres containing doxorubicin.
    Widder KJ; Morris RM; Poore G; Howard DP; Senyei AE
    Proc Natl Acad Sci U S A; 1981 Jan; 78(1):579-81. PubMed ID: 6941258
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Selective targeting of magnetic albumin microspheres containing low-dose doxorubicin: total remission in Yoshida sarcoma-bearing rats.
    Widder KJ; Morris RM; Poore GA; Howard DP; Senyei AE
    Eur J Cancer Clin Oncol; 1983 Jan; 19(1):135-9. PubMed ID: 6682771
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of albumin and casein microspheres as a carrier for doxorubicin.
    Chen Y; Willmott N; Anderson J; Florence AT
    J Pharm Pharmacol; 1987 Dec; 39(12):978-85. PubMed ID: 2894445
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The consequences of doxorubicin quinone reduction in vivo in tumour tissue.
    Cummings J; Willmott N; Hoey BM; Marley ES; Smyth JF
    Biochem Pharmacol; 1992 Dec; 44(11):2165-74. PubMed ID: 1472081
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of drug delivery following the administration of magnetic albumin microspheres containing adriamycin to the rat.
    Gallo JM; Gupta PK; Hung CT; Perrier DG
    J Pharm Sci; 1989 Mar; 78(3):190-4. PubMed ID: 2724075
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Covalent coupling of doxorubicin in protein microspheres is a major determinant of tumour drug disposition.
    Cummings J; Willmott N; Marley E; Smyth J
    Biochem Pharmacol; 1991 Jun; 41(12):1849-54. PubMed ID: 2039540
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Selective targeting of magnetic albumin microspheres to the Yoshida sarcoma: ultrastructural evaluation of microsphere disposition.
    Widder KJ; Marino PA; Morris RM; Howard DP; Poore GA; Senyei AE
    Eur J Cancer Clin Oncol; 1983 Jan; 19(1):141-7. PubMed ID: 6682772
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeted delivery of low dose doxorubicin hydrochloride administered via magnetic albumin microspheres in rats.
    Gupta PK; Hung CT
    J Microencapsul; 1990; 7(1):85-94. PubMed ID: 2308056
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Drug targeting: magnetically responsive albumin microspheres--a review of the system to date.
    Senyei AE; Widder KJ
    Gynecol Oncol; 1981 Aug; 12(1):1-13. PubMed ID: 7024051
    [No Abstract]   [Full Text] [Related]  

  • 11. Delivery of an anticancer drug and a chemosensitizer to murine breast sarcoma by intratumoral injection of sulfopropyl dextran microspheres.
    Liu Z; Ballinger JR; Rauth AM; Bendayan R; Wu XY
    J Pharm Pharmacol; 2003 Aug; 55(8):1063-73. PubMed ID: 12956895
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of carrier dose on the multiple tissue disposition of doxorubicin hydrochloride administered via magnetic albumin microspheres in rats.
    Gupta PK; Hung CT
    J Pharm Sci; 1989 Sep; 78(9):745-8. PubMed ID: 2585268
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy of mitoxantrone-loaded albumin microspheres for intratumoral chemotherapy of breast cancer.
    Almond BA; Hadba AR; Freeman ST; Cuevas BJ; York AM; Detrisac CJ; Goldberg EP
    J Control Release; 2003 Aug; 91(1-2):147-55. PubMed ID: 12932646
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Target organ disposition and plasma pharmacokinetics of doxorubicin incorporated into albumin microspheres after intrarenal arterial administration.
    Kerr DJ; Willmott N; McKillop JH; Cummings J; Lewi HJ; McArdle CS
    Cancer; 1988 Sep; 62(5):878-83. PubMed ID: 3409170
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro release of biologically active adriamycin by magnetically responsive albumin microspheres.
    Widder KJ; Senyei AE; Ranney DF
    Cancer Res; 1980 Oct; 40(10):3512-7. PubMed ID: 7438037
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intra-arterial administration of TNF-alpha followed by arterial ablation is an effective therapy for a regionally confined TNF-resistant rat mammary adenocarcinoma.
    Badgwell BD; Valentino DJ; Jeffes EB; Dieffenbach K; Dulkanchainun SB; Yamamoto RS; Granger GA; Jakowatz JG; Carson WE
    Cancer Immunol Immunother; 2003 Jan; 52(1):10-6. PubMed ID: 12536235
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative disposition of adriamycin delivered via magnetic albumin microspheres in presence and absence of magnetic field in rats.
    Gupta PK; Hung CT
    Life Sci; 1990; 46(7):471-9. PubMed ID: 2304381
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of medroxyprogesterone acetate and doxorubicin on sublines of 13762 mammary adenocarcinoma in rats.
    Formelli F; Zaccheo T; Casazza AM; Bellini O; Di Marco A
    Eur J Cancer Clin Oncol; 1981 Nov; 17(11):1211-21. PubMed ID: 6460631
    [No Abstract]   [Full Text] [Related]  

  • 19. Albumin microspheres as vehicles for the sustained and controlled release of doxorubicin.
    Jones C; Burton MA; Gray BN
    J Pharm Pharmacol; 1989 Dec; 41(12):813-6. PubMed ID: 2576441
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Percutaneous tumor ablation: increased necrosis with combined radio-frequency ablation and intravenous liposomal doxorubicin in a rat breast tumor model.
    Goldberg SN; Girnan GD; Lukyanov AN; Ahmed M; Monsky WL; Gazelle GS; Huertas JC; Stuart KE; Jacobs T; Torchillin VP; Halpern EF; Kruskal JB
    Radiology; 2002 Mar; 222(3):797-804. PubMed ID: 11867804
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.